News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  14 January 2016  
  Congratulations to IMCB’s recent PhD graduate
 
 



Thesis Title: CHARACTERIZATION OF THE PR-DOMAIN PROTEIN PRDM15: ROLE IN DEVELOPMENT AND CANCER

Supervisor: Ernesto GUCCIONE

Abstract
Members of the PR domain containing family of proteins (PRDMs) are master regulators of key cellular processes ranging from DNA recombination to transcriptional regulation, both in physiological (development and cell differentiation) and pathological (cancer) conditions. Here, we characterize a poorly studied member of the PRDM family, PRDM15, to uncover its role in mammalian development. We first derived conditional PRDM15 KO mouse Embryonic Stem Cells (mESCs) and characterized a fundamental role for PRDM15 in regulating ESCs homeostasis, self-renewal and cell fate decisions. At the molecular level, using high-throughput technologies (ChiP-seq, RNA-seq and quantitative Mass Spectrometry), we uncover both PRDM15 binding partners and direct transcriptional targets. Overall, our data suggest a role of PRDM15 in transcriptional repression of key pathways regulating early lineage specification (e.g. Wnt and Nodal). Next, we relied on Knockout mouse models to demonstrate that PRDM15 is essential during mammalian development, but not in the postnatal life.  Deletion of PRDM15 affects anterior/posterior patterning leading to severe brain defects during early developmental stages, and to embryonic lethality.

Collectively, our findings elucidate an essential role of PRDM15 in mouse development and in ESC homeostasis.

Figure legend: Schematic representation of the transcriptional targets of PRDM15 which are involved in i) regulation of the extended pluripotency network, Blue circles represent transcription factors co-occupying PRDM15 binding sites (e.g. STAT3, KLF4, TCFCP2L1 and ESRRB) ii) regulating key extracellular signaling pathways essential to ensure ESCs pluripotency and self-renewal as well as EMT, Anterior/Posterior patterning and forebrain development.

For more information on Ernesto GUCCIONE’s laboratory, please click here.